Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
Zubair Akhtar1,2, Mallory Trent1, Aye Moa1
1Biosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney Australia.
Insights
COVID-19 increases cardiovascular disease risk. While vaccination is generally protective, it can rarely cause myocarditis. Awareness of cardiac symptoms post-COVID-19 and vaccination is crucial for timely diagnosis and management.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- COVID-19 is a significant risk factor for developing cardiovascular disease.
- Cardiovascular complications of COVID-19 infection are diverse and include myocardial injury, arrhythmias, and heart failure.
- COVID-19 vaccination may offer protection but can rarely lead to myocarditis or pericarditis.
Purpose of the Study:
- To review the cardiovascular complications associated with COVID-19 infection.
- To evaluate the impact of COVID-19 vaccination on cardiovascular health.
- To highlight the need for improved diagnostic and referral pathways for cardiac symptoms post-COVID-19.
Main Methods:
- Systematic review of existing literature on COVID-19 and cardiovascular complications.
- Analysis of data regarding the incidence of myocarditis and pericarditis following COVID-19 infection and vaccination.
- Examination of diagnostic challenges for non-specific cardiac symptoms.
Main Results:
- COVID-19 infection is linked to myocardial injury, pericarditis, coagulopathy, myocardial infarction, heart failure, and arrhythmias.
- COVID-19 vaccination is generally cardioprotective, but myopericarditis is a rare adverse effect, particularly in young males.
- The rate of myopericarditis is lower following vaccination compared to SARS-CoV-2 infection.
Conclusions:
- Primary care physicians need increased awareness of potential cardiac origins for non-specific post-COVID-19 symptoms.
- Full vaccination with boosters, managing cardiovascular risk factors, and prompt COVID-19 treatment are recommended.
- Clear diagnostic and management pathways are essential for patients presenting with symptoms like fatigue and dyspnoea to rule out cardiac issues.
Abstract:
COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or pericarditis. Patients with COVID-19 may present with non-specific symptoms that have a cardiac origin. This review examines the cardiovascular complications of COVID-19 infection and the impact of COVID-19 vaccination. COVID-19 cardiovascular complications include myocardial injury, pericarditis, coagulopathy, myocardial infarction, heart failure, arrhythmias, and persistent post-acute risk of adverse cardiovascular outcomes. Diagnostic and referral pathways for non-specific symptoms, such as dyspnoea and fatigue, remain unclear. COVID-19 vaccination is cardioprotective overall but is associated with myopericarditis in young males, though at a lower rate than following SARS-CoV-2 infection. Increased awareness among primary care physicians of potential cardiovascular causes of non-specific post-COVID-19 symptoms, including in younger adults, such as fatigue, dyspnoea, and chest pain, is essential. We recommend full vaccination with scheduled booster doses, optimal management of cardiovascular risk factors, rapid treatment of COVID-19, and clear diagnostic, referral, and management pathways for patients presenting with non-specific symptoms to rule out cardiac complications.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

